All sites C00-96,D32-33,D42-43,D45-47,D76 225 89.8 4.0 3.7 0.6 1.8
Mouth, pharynx C00-14 4 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 - - - - - -
Digestive organs C15-26 40 81.0 7.0 8.0 0.5 3.5
  Oesophagus C15 1 80.0 20.0 - - -
  Stomach C16 5 100.0 - - - -
  Small intestine C17 0 100.0 - - - -
  Colon C18 13 92.1 - 3.2 - 4.8
  Rectum, rectosigmoid C19-20 5 100.0 - - - -
  Anus C21 - - - - - -
  Liver C22 2 66.7 16.7 16.7 - -
  Gallbladder, bile ducts C23-24 3 57.1 14.3 21.4 - 7.1
  Pancreas C25 10 60.8 17.6 15.7 - 5.9
  Other digestive organs C26 1 60.0 - 20.0 20.0 -
Respiratory organs C30-39 11 72.7 16.4 9.1 - 1.8
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 10 75.0 17.3 7.7 - -
  Mediastinum, pleura C38 1 33.3 - 33.3 - 33.3
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 8 100.0 - - - -
Skin, non-melanoma C44 13 100.0 - - - -
Mesothelioma C45 - - - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 67 99.4 0.6 - - -
Female genital organs C51-58 22 93.6 1.8 1.8 1.8 0.9
  Cervix uteri C53 2 100.0 - - - -
  Corpus uteri C54 10 98.1 1.9 - - -
  Uterus, other C55,C58 0 - - 50.0 50.0 -
  Ovary C56 6 90.0 3.3 - 3.3 3.3
  Other female genital C51-52,C57 3 93.8 - 6.3 - -
Urinary organs C64-68 11 92.6 - 5.6 1.9 -
  Kidney C64 6 93.8 - 3.1 3.1 -
  Bladder and urinary tract2 C65-68 4 90.9 - 9.1 - -
Eye C69 0 - 100.0 - - -
Brain, central nervous system C70-72,D32-33,D42-43 9 79.5 - 15.9 - 4.5
Thyroid gland C73 9 97.7 2.3 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 9 53.2 19.1 14.9 2.1 10.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 19 84.0 7.4 2.1 2.1 4.3
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 8 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 4 78.9 10.5 5.3 5.3 -
  Leukaemia C91-95 4 80.0 15.0 5.0 - -
  Myelodysplastic syndromes D46 1 50.0 16.7 - - 33.3
  Myeloproliferaitive neoplasms D45,D47 1 20.0 20.0 - 20.0 40.0
Not included above
  Carcinoma in situ of the breast D05 5 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 3 100.0 - - - -
  Borderline tumour of the ovary D39 2 100.0 - - - -
  Basal cell carcinoma of the skin 63 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.